Global Health Future Growth
Future criteria checks 4/6
Global Health is forecast to grow earnings and revenue by 24.6% and 17.2% per annum respectively. EPS is expected to grow by 24.7% per annum. Return on equity is forecast to be 19.9% in 3 years.
Key information
24.6%
Earnings growth rate
24.7%
EPS growth rate
Healthcare earnings growth | 27.4% |
Revenue growth rate | 17.2% |
Future return on equity | 19.9% |
Analyst coverage | Good |
Last updated | 08 Apr 2024 |
Recent future growth updates
Recent updates
Do Global Health's (NSE:MEDANTA) Earnings Warrant Your Attention?
Apr 12Is Global Health (NSE:MEDANTA) A Risky Investment?
Mar 22Market Participants Recognise Global Health Limited's (NSE:MEDANTA) Earnings Pushing Shares 32% Higher
Feb 13There's Been No Shortage Of Growth Recently For Global Health's (NSE:MEDANTA) Returns On Capital
Jan 18With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case
Dec 26Global Health Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jun 01Global Health Limited's (NSE:MEDANTA) Earnings Haven't Escaped The Attention Of Investors
Mar 30Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 46,503 | 7,809 | 5,181 | N/A | 8 |
3/31/2025 | 39,243 | 6,258 | 3,678 | N/A | 8 |
3/31/2024 | 33,472 | 4,924 | 2,383 | N/A | 8 |
12/31/2023 | 31,660 | 4,519 | N/A | N/A | N/A |
9/30/2023 | 30,277 | 4,089 | 4,024 | 6,400 | N/A |
6/30/2023 | 28,498 | 3,694 | N/A | N/A | N/A |
3/31/2023 | 27,072 | 3,261 | 4,085 | 6,445 | N/A |
12/31/2022 | 25,164 | 2,426 | N/A | N/A | N/A |
6/30/2022 | 23,043 | 2,132 | 1,109 | 3,724 | N/A |
3/31/2022 | 21,725 | 1,962 | 368 | 3,113 | N/A |
3/31/2021 | 14,519 | 288 | 960 | 2,418 | N/A |
3/31/2020 | 15,182 | 363 | -132 | 1,751 | N/A |
3/31/2019 | 14,782 | 610 | -1,496 | 1,501 | N/A |
3/31/2018 | 13,677 | 329 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MEDANTA's forecast earnings growth (24.6% per year) is above the savings rate (6.7%).
Earnings vs Market: MEDANTA's earnings (24.6% per year) are forecast to grow faster than the Indian market (18% per year).
High Growth Earnings: MEDANTA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MEDANTA's revenue (17.2% per year) is forecast to grow faster than the Indian market (10.3% per year).
High Growth Revenue: MEDANTA's revenue (17.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MEDANTA's Return on Equity is forecast to be low in 3 years time (19.9%).